Chemical materials

Mitazalimab (anti-CD40)

Mitazalimab (anti-CD40)

AL-AB182809 / 5MG
CAS No.:2055640-86-1
Add to Inquiry
Zalifrelimab (anti-CTLA-4)

Zalifrelimab (anti-CTLA-4)

AL-AB182811 / 10MG
CAS No.:2148321-69-9
Add to Inquiry
Zalifrelimab (anti-CTLA-4)

Zalifrelimab (anti-CTLA-4)

AL-AB182811 / 5MG
CAS No.:2148321-69-9
Add to Inquiry
Zalifrelimab (anti-CTLA-4)

Zalifrelimab (anti-CTLA-4)

AL-AB182811 / 1MG
CAS No.:2148321-69-9
Add to Inquiry
Zalifrelimab (anti-CTLA-4)

Zalifrelimab (anti-CTLA-4)

AL-AB182811 / 100ΜG
CAS No.:2148321-69-9
Add to Inquiry
Balstilimab (anti-PD-1)

Balstilimab (anti-PD-1)

AL-AB182812 / 10MG
CAS No.:2148321-77-9
Add to Inquiry
Balstilimab (anti-PD-1)

Balstilimab (anti-PD-1)

AL-AB182812 / 100ΜG
CAS No.:2148321-77-9
Add to Inquiry
Balstilimab (anti-PD-1)

Balstilimab (anti-PD-1)

AL-AB182812 / 5MG
CAS No.:2148321-77-9
Add to Inquiry
Balstilimab (anti-PD-1)

Balstilimab (anti-PD-1)

AL-AB182812 / 1MG
CAS No.:2148321-77-9
Add to Inquiry
Lirentelimab (anti-Siglec-8)

Lirentelimab (anti-Siglec-8)

AL-AB182813 / 10MG
CAS No.:2283348-97-8
Add to Inquiry
Lirentelimab (anti-Siglec-8)

Lirentelimab (anti-Siglec-8)

AL-AB182813 / 100ΜG
CAS No.:2283348-97-8
Add to Inquiry
Lirentelimab (anti-Siglec-8)

Lirentelimab (anti-Siglec-8)

AL-AB182813 / 1MG
CAS No.:2283348-97-8
Add to Inquiry
Lirentelimab (anti-Siglec-8)

Lirentelimab (anti-Siglec-8)

AL-AB182813 / 5MG
CAS No.:2283348-97-8
Add to Inquiry
Ivuxolimab (anti-CD134)

Ivuxolimab (anti-CD134)

AL-AB182815 / 5MG
CAS No.:2128729-41-7
Add to Inquiry
Ivuxolimab (anti-CD134)

Ivuxolimab (anti-CD134)

AL-AB182815 / 10MG
CAS No.:2128729-41-7
Add to Inquiry
Ivuxolimab (anti-CD134)

Ivuxolimab (anti-CD134)

AL-AB182815 / 100ΜG
CAS No.:2128729-41-7
Add to Inquiry
Ivuxolimab (anti-CD134)

Ivuxolimab (anti-CD134)

AL-AB182815 / 1MG
CAS No.:2128729-41-7
Add to Inquiry
Cevostamab (anti-CD3&FCRL5)

Cevostamab (anti-CD3&FCRL5)

AL-AB182817 / 100ΜG
CAS No.:2249888-53-5
Add to Inquiry
Cevostamab (anti-CD3&FCRL5)

Cevostamab (anti-CD3&FCRL5)

AL-AB182817 / 1MG
CAS No.:2249888-53-5
Add to Inquiry
Cevostamab (anti-CD3&FCRL5)

Cevostamab (anti-CD3&FCRL5)

AL-AB182817 / 5MG
CAS No.:2249888-53-5
Add to Inquiry
Cevostamab (anti-CD3&FCRL5)

Cevostamab (anti-CD3&FCRL5)

AL-AB182817 / 10MG
CAS No.:2249888-53-5
Add to Inquiry
Setrusumab (anti-Sclerostin)

Setrusumab (anti-Sclerostin)

AL-AB182819 / 10MG
CAS No.:1847394-95-9
Add to Inquiry
Setrusumab (anti-Sclerostin)

Setrusumab (anti-Sclerostin)

AL-AB182819 / 100ΜG
CAS No.:1847394-95-9
Add to Inquiry
Setrusumab (anti-Sclerostin)

Setrusumab (anti-Sclerostin)

AL-AB182819 / 1MG
CAS No.:1847394-95-9
Add to Inquiry
Setrusumab (anti-Sclerostin)

Setrusumab (anti-Sclerostin)

AL-AB182819 / 5MG
CAS No.:1847394-95-9
Add to Inquiry
Melrilimab (anti-IL-33R)

Melrilimab (anti-IL-33R)

AL-AB182821 / 1MG
CAS No.:2222865-46-3
Add to Inquiry
Melrilimab (anti-IL-33R)

Melrilimab (anti-IL-33R)

AL-AB182821 / 100ΜG
CAS No.:2222865-46-3
Add to Inquiry
Melrilimab (anti-IL-33R)

Melrilimab (anti-IL-33R)

AL-AB182821 / 10MG
CAS No.:2222865-46-3
Add to Inquiry
Melrilimab (anti-IL-33R)

Melrilimab (anti-IL-33R)

AL-AB182821 / 5MG
CAS No.:2222865-46-3
Add to Inquiry
Ieramilimab (anti-LAG3)

Ieramilimab (anti-LAG3)

AL-AB182825 / 100ΜG
CAS No.:2137049-37-5
Add to Inquiry
Ieramilimab (anti-LAG3)

Ieramilimab (anti-LAG3)

AL-AB182825 / 5MG
CAS No.:2137049-37-5
Add to Inquiry
Ieramilimab (anti-LAG3)

Ieramilimab (anti-LAG3)

AL-AB182825 / 10MG
CAS No.:2137049-37-5
Add to Inquiry
Ieramilimab (anti-LAG3)

Ieramilimab (anti-LAG3)

AL-AB182825 / 1MG
CAS No.:2137049-37-5
Add to Inquiry
Elgemtumab (anti-ERBB3)

Elgemtumab (anti-ERBB3)

AL-AB182826 / 1MG
CAS No.:1512559-37-3
Add to Inquiry
Elgemtumab (anti-ERBB3)

Elgemtumab (anti-ERBB3)

AL-AB182826 / 5MG
CAS No.:1512559-37-3
Add to Inquiry
Elgemtumab (anti-ERBB3)

Elgemtumab (anti-ERBB3)

AL-AB182826 / 10MG
CAS No.:1512559-37-3
Add to Inquiry
Elgemtumab (anti-ERBB3)

Elgemtumab (anti-ERBB3)

AL-AB182826 / 100ΜG
CAS No.:1512559-37-3
Add to Inquiry
Frovocimab (anti-PCSK9)

Frovocimab (anti-PCSK9)

AL-AB182827 / 10MG
CAS No.:1643672-70-1
Add to Inquiry
Frovocimab (anti-PCSK9)

Frovocimab (anti-PCSK9)

AL-AB182827 / 5MG
CAS No.:1643672-70-1
Add to Inquiry
Frovocimab (anti-PCSK9)

Frovocimab (anti-PCSK9)

AL-AB182827 / 1MG
CAS No.:1643672-70-1
Add to Inquiry
Frovocimab (anti-PCSK9)

Frovocimab (anti-PCSK9)

AL-AB182827 / 100ΜG
CAS No.:1643672-70-1
Add to Inquiry
Lodapolimab (anti-PD-L1)

Lodapolimab (anti-PD-L1)

AL-AB182828 / 100ΜG
CAS No.:2118349-31-6
Add to Inquiry
Lodapolimab (anti-PD-L1)

Lodapolimab (anti-PD-L1)

AL-AB182828 / 5MG
CAS No.:2118349-31-6
Add to Inquiry
Lodapolimab (anti-PD-L1)

Lodapolimab (anti-PD-L1)

AL-AB182828 / 1MG
CAS No.:2118349-31-6
Add to Inquiry
Lodapolimab (anti-PD-L1)

Lodapolimab (anti-PD-L1)

AL-AB182828 / 10MG
CAS No.:2118349-31-6
Add to Inquiry
Tavolixizumab (anti-CD134)

Tavolixizumab (anti-CD134)

AL-AB182830 / 1MG
CAS No.:1635395-25-3
Add to Inquiry
Tavolixizumab (anti-CD134)

Tavolixizumab (anti-CD134)

AL-AB182830 / 5MG
CAS No.:1635395-25-3
Add to Inquiry
Tavolixizumab (anti-CD134)

Tavolixizumab (anti-CD134)

AL-AB182830 / 100ΜG
CAS No.:1635395-25-3
Add to Inquiry
Tavolixizumab (anti-CD134)

Tavolixizumab (anti-CD134)

AL-AB182830 / 10MG
CAS No.:1635395-25-3
Add to Inquiry
Prasinezumab (anti-Alpha-synuclein)

Prasinezumab (anti-Alpha-synuclein)

AL-AB182835 / 5MG
CAS No.:1960462-19-4
Add to Inquiry
LOCATIONS

Service location

Taipei, New Taipei, Keelung / Yilan / Hualien
Inquiry Cart

Your inquiry Cart total 0 items

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
Manage Cookies

Privacy Preference Center

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
View Privacy Policy

Manage Consent Settings

Necessary Cookies

Enable all
The operation of the website relies on these cookies, and you cannot disable them in the system. These cookies are usually set based on the actions you take (i.e., service requests), such as setting privacy preferences, logging in, or filling out forms. You can set your browser to block or prompt you about these cookies, but this may cause some website functions to stop working.